Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; the references it cites are not checked yet.

Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025

Open access

Abstract

Epithelial-to-mesenchymal transition (EMT) is a crucial cellular process for embryogenesis, wound healing, and cancer progression. It involves a shift in cell interactions, leading to the detachment of epithelial cells and activation of gene programs promoting a mesenchymal state. EMT plays a significant role in cancer metastasis triggering tumor initiation and stemness, and activates metastatic cascades resulting in resistance to therapy. Moreover, reversal of EMT contributes to the formation of metastatic lesions. Metastasis still needs to be better understood functionally in its major but complex steps of migration, invasion, intravasation, dissemination, which contributes to the establishment of minimal residual disease (MRD), extravasation, and successful seeding and growth of metastatic lesions at microenvironmentally heterogeneous sites. Therefore, the current review article intends to present, and discuss comprehensively, the status quo of experimental models able to investigate EMT and metastasis in vitro and in vivo, for researchers planning to enter the field. We emphasize various methods to understand EMT function and the major steps of metastasis, including diverse migration, invasion and matrix degradation assays, microfluidics, 3D co-culture models, spheroids, organoids, or latest spatial and imaging methods to analyze complex compartments. In vivo models such as the chorionallantoic membrane (CAM) assay, cell line-derived and patient-derived xenografts, syngeneic, genetically modified, and humanized mice, are presented as a promising arsenal of tools to analyze intravasation, site specific metastasis, and treatment response. Furthermore, we give a brief overview on methods detecting dissemination and MRD in carcinomas, highlighting its significance in tracking the course of disease and response to treatment. Enhanced lineage tracking tools, dynamic in vivo imaging, and therapeutically useful in vivo models as powerful preclinical tools may still better reveal functional interdependencies between metastasis and EMT. Future directions are discussed in light of emerging views on the biology, diagnosis, and treatment of EMT and metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12943-025-02338-2

Cites

Statistics

Figures

Fig. 1 A schematic illustration depicting epithelial-to-mesenchymal transition (EMT) and the metastatic cascade. The figure shows tumor cells undergoing EMT, characterized by the reduction of epithelial markers and the acquisition of mesenchymal properties, promoting migration and invasion. Cancer cells then enter the vasculature, disseminate as disseminating tumor cells (DTCs), and extravasate to distant sites
Fig. 1 A schematic illustration depicting epithelial-to-mesenchymal transition (EMT) and the metastatic cascade. The figure shows tumor cells undergoing EMT, characterized by the reduction of epithelial markers and the acquisition of mesenchymal properties, promoting migration and invasion. Cancer cells then enter the vasculature, disseminate as disseminating tumor cells (DTCs), and extravasate to distant sitesCC BY-NC-ND · PubMed Central
Fig. 2 Depiction of various 2D and 3D in vitro models to study EMT in Cancer. In 2D culture, cells grow under adherent conditions, which confine them to microenvironment. These models are easy to implement, however, they only support to study cell–cell interactions. In contrast, 3D culture models mimic the tumor microenvironment by enabling both cell–cell and cell–matrix interactions within a three-dimensional structure. Moreover, 3D models allow for the co-culture of multiple cell types, effectively mimicking intra-tumor heterogeneity
Fig. 2 Depiction of various 2D and 3D in vitro models to study EMT in Cancer. In 2D culture, cells grow under adherent conditions, which confine them to microenvironment. These models are easy to implement, however, they only support to study cell–cell interactions. In contrast, 3D culture models mimic the tumor microenvironment by enabling both cell–cell and cell–matrix interactions within a three-dimensional structure. Moreover, 3D models allow for the co-culture of multiple cell types, effectively mimicking intra-tumor heterogeneityCC BY-NC-ND · PubMed Central
Fig. 3 Schematic representation of the chorionallantoic membrane (CAM) model of the bred chicken egg and possible applications for cancer research. Schematic overview of the developing egg. Possible material to be used for the CAM model and potential applications (materials or compounds) are shown at the top level of the graph. Major compartments of the egg model are shown, including the lower and upper CAMs which are physiologically defined with respect to the window cut for placing the cells/material to be investigated (dotted line). Many implications of the model for cancer research are demonstrated in the lower part of the figure. Especially, after inoculation of the cells or tissues onto the CAM, invasion into the upper CAM can be measured, as well as tumor growth and angiogenesis. The lower CAM can be harvested specifically to evaluate the cells that have intravasated into blood vessels. PDX models are also possible. The model is excellent for rapid in vivo drug testing, amongst all of the other applications shown
Fig. 3 Schematic representation of the chorionallantoic membrane (CAM) model of the bred chicken egg and possible applications for cancer research. Schematic overview of the developing egg. Possible material to be used for the CAM model and potential applications (materials or compounds) are shown at the top level of the graph. Major compartments of the egg model are shown, including the lower and upper CAMs which are physiologically defined with respect to the window cut for placing the cells/material to be investigated (dotted line). Many implications of the model for cancer research are demonstrated in the lower part of the figure. Especially, after inoculation of the cells or tissues onto the CAM, invasion into the upper CAM can be measured, as well as tumor growth and angiogenesis. The lower CAM can be harvested specifically to evaluate the cells that have intravasated into blood vessels. PDX models are also possible. The model is excellent for rapid in vivo drug testing, amongst all of the other applications shownCC BY-NC-ND · PubMed Central
Fig. 4 Schematic illustration of experimental mouse models to study metastasis. Syngeneic mouse models involve spontaneous development of tumors or transplantation of tumors within the same strain. Genetically engineered mouse models have targeted gene mutations which enable tumor development to be monitored from the initial stages. Immunocompromised mice are used for xenotransplantation of human tissues or cells. In the CDX model, a tumor is developed by injecting cells from established tumor cell lines into mice, whereas in the PDX model, the tumor is derived from human tumor tissue, mimicking the human tumor microenvironment. These tumors can be expanded within the same strain, facilitating metastatic studies. In humanized mouse models, the mice are inoculated with human cells (e.g., immune or stromal cells) to study tumor interactions with human normal cells. The PDXO model involves implanting human tumor tissue into mice to create 3D organoid cultures, which mimic the human tumor environment
Fig. 4 Schematic illustration of experimental mouse models to study metastasis. Syngeneic mouse models involve spontaneous development of tumors or transplantation of tumors within the same strain. Genetically engineered mouse models have targeted gene mutations which enable tumor development to be monitored from the initial stages. Immunocompromised mice are used for xenotransplantation of human tissues or cells. In the CDX model, a tumor is developed by injecting cells from established tumor cell lines into mice, whereas in the PDX model, the tumor is derived from human tumor tissue, mimicking the human tumor microenvironment. These tumors can be expanded within the same strain, facilitating metastatic studies. In humanized mouse models, the mice are inoculated with human cells (e.g., immune or stromal cells) to study tumor interactions with human normal cells. The PDXO model involves implanting human tumor tissue into mice to create 3D organoid cultures, which mimic the human tumor environmentCC BY-NC-ND · PubMed Central
Fig. 5 Comprehensive overview of the metastatic cascade and techniques that can be applied at each stage. Schematic overview of key in vitro and in vitro applications and animal models to investigate individual steps of the cascade of metastasis
Fig. 5 Comprehensive overview of the metastatic cascade and techniques that can be applied at each stage. Schematic overview of key in vitro and in vitro applications and animal models to investigate individual steps of the cascade of metastasisCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 437 · Cited by 127

Research works printed but not linked: 1

  1. Bender DH, Friedgood CE, Lee HF. Transplantation of heterologous tumors by the intravenous inoculation of the chick embryo. Cancer Res. 1949;9:61–4.

Metadata

Authors
Allgayer, H., Mahapatra, S., Mishra, B., Swain, B., Saha, S., Khanra, S., Kumari, K., Panda, V. K., Malhotra, D., Patil, N. S., Leupold, J. H., & Kundu, G. C.
Affiliations
  • Heidelberg University (DE)
  • KIIT University (IN)
Corresponding author
  • Allgayer, Heike
  • Kundu, Gopal C.
Venue
Molecular Cancer
Published
2025-06-07
Volume
24
Issue
1
Pages
167-167
ISSN
1476-4598 (ISSN-L)
OpenAlex
W4411080498
Cited by
127
References
437
Citations by year
2026: 106 · 2025: 21
FWCI
14.85
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Cancer (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Wilhelm Sander Foundation, Munich (2022.119.1)
  • Dr. Rolf M Schwiete Foundation, Mannheim (2022-37)
  • Alfried Krupp von Bohlen und Halbach Foundation, Essen
  • The Hella-Buehler-Foundation, Heidelberg
  • ANRF-Science and Engineering Research Board (ANRF-SERB), Govt. of India (JCB/2023/000011)
  • Indian Council of Medical Research (ICMR), New Delhi, Govt. of India (EM/SG/Dev.Res/114/6828-2023)
  • Department of Biotechnology (DBT), New Delhi, Govt. of India (BT/PR39330/DRUG/134/88/2021)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
epithelial-mesenchymal transition, metastasis, experimental model, cell migration, cell invasion, extracellular matrix degradation, microfluidics, 3D co-culture model, organoids, spheroids, patient-derived xenografts, humanized mice, minimal residual disease, lineage tracing, in vivo imaging, preclinical models
MeSH terms
Animals, Humans, Neoplasm Metastasis, Neoplasms, Epithelial-Mesenchymal Transition, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025. https://app.cochat.ai/papers/10.1186/s12943-025-02338-2
The paper
Allgayer, H., Mahapatra, S., Mishra, B., Swain, B., Saha, S., Khanra, S., Kumari, K., Panda, V. K., Malhotra, D., Patil, N. S., Leupold, J. H., & Kundu, G. C. (2025). Epithelial-to-mesenchymal transition (EMT) and cancer metastasis: the status quo of methods and experimental models 2025. Molecular Cancer. https://doi.org/10.1186/s12943-025-02338-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.